Clinical Trial Update: Comparison of the Clinical Efficacy and Safety of Topical and Subcutaneous Injection of Secukinumab in HS [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 study comparing topical versus subcutaneous secukinumab for hidradenitis suppurativa, currently not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Secukinumab (secukinumab)

Snippet

Sponsor: Peking Union Medical College | Conditions: Hidradenitis Suppurativa (HS), Hidradenitis Suppurativa (Acne Inversa) | Phase 4 | Status: NOT_YET_RECRUITING